Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-21

FDA Approved: BRIMONIDINE TARTRATE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved the original application for Brimonidine Tartrate by Apotex Corp., adding a generic option for treating glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)